Join the 'Pomalyst' group to help and get support from people like you.
Pomalyst Support Group
No questions were found associated with the 'Pomalyst' support group.
Related Condition Support Groups
Pomalyst Patient Information at Drugs.com
FDA Approves Empliciti (elotuzumab) Plus Pomalidomide and Dexamethasone, a New Immunotherapy Combination for Certain Patients with Relapsed or Refractory Multiple Myeloma
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Empliciti (elotuzumab) injection for intravenous ...